Digital tomosynthesis versus DR following hand and wrist surgery with hardware.
Post-operative digital tomosynthesis (DTS) provides more visibility than digital radiography (DR) to confirm placement of orthopedic hardware following trauma or arthrodesis in the hand and wrist, according to a study published in Clinical Radiology.
Researchers from Switzerland performed a prospective study to investigate using DTS as an alternative to DR following surgery to insert orthopedic hardware in the hand and wrist.
A total of 36 patients participated in the study. Their mean age was 36 and 12 patients were women. Imaging was performed with DTS in dorso-palmar projection and DR was performed in dorso-palmar, lateral, and oblique views. The images were evaluated by two independent radiologists for qualitative and diagnosis-related imaging parameters using a four-point Likert scale (1=excellent, 4=not diagnostic) and nominal scale.
The results showed that interobserver agreement was higher for the image quality with DTS compared to DR. This was even more apparent for fracture-related parameters. Delineation of fracture margins and delineation of adjacent joint spaces scored significantly better for DTS compared to DR.
Interobserver agreement was almost equal when looking at diagnosis-related findings. DTS showed a significant higher sharpness of fracture margins and mean dose area product (DAP) for DTS was significantly higher compared to DR.
The researchers concluded that DTS was superior to DR when examining images for fracture healing and interobserver agreement was higher for DTS compared to DR in the postoperative assessment of orthopedic hardware in the hand and wrist.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.